Eric Matthew George

Affiliations: 
The University of Mississippi Medical Center, Jackson, MS, United States 
Area:
pregnancy, preeclampsia, vascular biology, epigenetics
Google:
"Eric George"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Waller JP, Howell JA, Peterson H, et al. (2021) Elastin-Like Polypeptide: VEGF-B Fusion Protein for Treatment of Preeclampsia. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12117
Moore KH, Murphy HA, Chapman H, et al. (2021) Syncytialization alters the extracellular matrix and barrier function of placental trophoblasts. American Journal of Physiology. Cell Physiology
Moore KH, Murphy HA, George EM. (2021) The Glycocalyx: A Central Regulator of Vascular Function. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Bakrania BA, George EM, Granger JP. (2020) Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. American Journal of Obstetrics and Gynecology
Moore KH, Chapman H, George EM. (2020) Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix. Biology of Sex Differences. 11: 34
Eddy A, Chapman H, Brown DT, et al. (2020) Differential Regulation of sFlt-1 Splicing by U2AF65 and JMJD6 in Placental-Derived and Endothelial Cells. Bioscience Reports
Mahmoudi E, Cates C, Chapman H, et al. (2020) Hypoxia‐Induced Syndecan 1 Shedding in Placental Trophoblasts is Associated with Increased Peroxide The Faseb Journal. 34: 1-1
Eddy AC, Howell JA, Chapman H, et al. (2019) Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913
Eddy AC, Chapman H, George EM. (2019) Heparanase regulation of sFLT-1 release in trophoblasts in vitro. Placenta
LOGUE OC, EDDY AC, MOORE K, et al. (2019) Abstract P3045: The ELP-VEGF Fusion Protein Is Bioavailable After Subcutaneous Administration And Prevents Increased Blood Pressure In Response To Placental Ischemia Hypertension. 74
See more...